The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020

UCSF Abdominal And Pelvic Imaging 2020
August 2, 2020
Echocardiography – A Comprehensive Review 2020
August 2, 2020

The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020

Product Details

  • Oakstone Price: $1095.
  • Format: 59 Video Files (.mp4 format) + 2 PDF files.
  • File Size: 6.74 GB.
  • Download Link Below.

Download Link:

This post contains protected content. You must contact us to unlock it.


Description:

The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020

Brigham and Women’s Hospital Board Review

This comprehensive CME program offers an in-depth, case-base review of the clinical essentials in hematology and oncology. Ideal for MOC.

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. In this CME program, expert speakers address relevant topics in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Apply new knowledge to the ABIM certification/recertification hematology and oncology examinations

Topics/Speaker :

  • Molecular Genetics of Cancer – Nikhil Wagle, MD
  • Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD
  • Infections in Cancer Patients – Lindsey Baden, MD
  • Symptom Management in Patients with Cancer – Andrew J. Lawton, MD
  • Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD
  • Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
  • Acute Leukemias – Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome – David P. Steensma, MD
  • Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
  • Myeloproliferative Syndromes – Ann M. Mullally, MD
  • Multiple Myeloma – Kenneth C. Anderson, MD
  • Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD
  • Low Grade Lymphomas – Caron A. Jacobson, MD
  • High Grade Lymphomas – Eric D. Jacobsen, MD
  • Hodgkin’s Lymphoma – Jennifer L. Crombie, MD
  • Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
  • Head and Neck Cancer – Robert I. Haddad, MD
  • Natural History, Screening, Surgery and Small Cell Lung Cancer – Bruce E. Johnson, MD
  • Non Small Cell Lung Cancer – Mark Awad, MD, PhD
  • Mesothelioma and Thymoma – David M. Jackman, MD
  • Thyroid Cancer – Jochen Lorch, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors – Jennifer Ang Chan, MD
  • Esophageal and Gastric Cancer – Peter C. Enzinger, MD
  • Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD
  • Anal Cancers – Robert J. Mayer, MD
  • Colorectal Cancers – Robert J. Mayer, MD
  • Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD
  • Germ Cell Tumor: Maximizing Cure While Minimizing the Burden of Therapy – Mark M. Pomerantz, MD
  • Renal and Bladder Cancer – Guru P. Sonpavde, MBBS
  • Prostate Cancer Part I: Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD
  • Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD
  • Melanoma – F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD
  • Ovarian Cancer – Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
  • Neuro-oncology – David A. Reardon, MD
  • Breast Cancer: Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
  • Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
  • Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
  • Management of Metastatic Breast Cancer – Erica Mayer, MD, MPH
  • Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
  • Hematopoiesis and Cytokines – David T. Scadden, MD
  • Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
  • Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD
  • Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD
  • Anemia: An Overview – Ronald P. McCaffrey, MD
  • Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD
  • Immune Hemolytic Anemia – Richard M. Kaufman, MD
  • Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
  • Sickle Cell Disease – Maureen M. Achebe, MD, MPH
  • Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
  • Disorders of Neutrophils – Nancy Berliner, MD
  • Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
  • Hemophilia – Aric D. Parnes, MD
  • Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
  • Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
  • Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD
  • Transfusion Medicine for the Clinician – Walter H. Dzik, MD

Leave a Reply

Your email address will not be published. Required fields are marked *

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

USMLE Shop for USMLE/Boards will use the information you provide on this form to be in touch with you and to provide updates and marketing.